1. [Team Name] Monthly Technical Report [Safe Genes Program]
Project PoP: [Start and End Dates for the project]
Reporting Period: [dates report covers]
Briefing Prepared for Renee Wegrzyn
Distribution Statement

2. Distribution Statement
Project Overview
A few bullets or figures that serve as a reminder of the key goals of the project, and why it’s “DARPA hard”.
Distribution Statement

3. Accomplishments and Challenges to Date
Accomplishments (cumulative):
List 1-5 bullets that cover your technical accomplishments to date – these are the big wins and key proofs-of-concept. Be sure to include any successful transitions
Summarize all of the publications, patents, spin-off companies, etc that have resulted from this work (you can use a separate slide)
Challenges:
please include 1-3 condensed bullets discussing the technical challenges you faced, and if/how you overcame them.
Primary focus is to summarize your accomplishments and challenges since the start of the effort.
Distribution Statement

4. Technical Progress - Executive Overview
Technical progress update:
List 1-5 bullets that cover your progress, to include but not limited to, technical accomplishments, technical status, notable events/publications, deliverables achieved..; Set up the story you are about to tell in the supporting data slides with regard to your progress or problems.
Primary focus is to summarize your technical progress during the last reporting period and identify potential timeline issues.
Distribution Statement

5. Milestones and Task Status Overview
Insert table of objectives, quantitative metrics, and milestones as listed in the original or approved contract modifications. List the current status for (percentage of completion and date to be completed)-(declare whether ahead of schedule, as scheduled, or behind schedule).
For all tasks active or scheduled to be active this past quarter, provide the information indicated in the example table below:
[Team Name] Active Task Status – Past Month
Date:
SOW Task #
Contract Start
Due Date
Actual Start
Actual Finish
Status (%)
Exit Criteria (Milestones and Deliverables)
Issues and Status
1.0
Task description  
1.1
Subtask description
1/1/2014
3/31/2014
100%
1.2
2/28/2014
5/31/2014
1.3
6/30/2014
1.4
11/1/2014
50%
1.5
12/15/2014
25%
2.0
2.1
MM/DD/YYYY
2.2
2.3
2.4
2.5
Distribution Statement

6. [Task Identifier and Title (e.g. 1.3 – Biofidelic Modeling)]
For tasks with key progress during this reporting period, please include a slide with supporting figures/images/videos:
figure/image/video
[Brief text description]
Distribution Statement

7. Exit Criteria (Milestones and Deliverables)
Upcoming Tasks
Anticipated work for next reporting period:
please include 1-3 condensed bullets discussing your planned efforts for the *next* reporting period
For ADDITIONAL tasks that will be active or are scheduled to be active NEXT reporting period, provide the information indicated in the example table below:
[Team Name] New Tasks in Coming Month
Date:
SOW Task #
Contract Start
Due Date
Actual Start
Predicted Finish
Status (%)
Exit Criteria (Milestones and Deliverables)
Reason for Delay
1.0
Task description  
1.6
Subtask description
1/1/2014
3/31/2014
100%
 N/A
1.7
2/28/2014
5/31/2014
1.8
6/30/2014
1.9
11/1/2014
50%
 IRB resubmission
2.0
2.6
MM/DD/YYYY
3.0
Task description
3.6
3.7
Distribution Statement

8. Public Affairs and Public Engagement
Publications
Drafts In Progress – Attach manuscripts in pre-print
Published
Meetings
Upcoming Dates and Audience – Attach slides
Meeting Outcomes and Follow up
Items for Public Release
Attach drafts of press releases, slides, manuscripts, articles, etc at least one month in advance of date needed for distribution
Distribution Statement

9. Additional slides to consider as needed…
Data sharing and analysis
Scope of the files and opportunities to support and grow data storage and sharing
Platforms used
Data files uploaded with parameters, context
Engagement (if not a task reported above)
LEEDR Panel – one-on-one or issues for upcoming quarterly calls
Communities
Regulatory – Include Organizations and POCs
Other
Compliance
Animal protocols
Biological Safety
Confirm not HSR
Other IRB issues or other biosafety approvals/data calls, i.e., for BWC, etc.)
Other attachments for DARPA PM/COR/CO awareness or comment
Distribution Statement

10. Additional Items for Discussion
Administrative Issues
Questions or Concerns not addressed in previous slides
Major challenges
Distribution Statement

11. Distribution Statement
Detailed spend plan
Financials: [Indicate original spend plan in contract, percent of funds expended, balance relative to spend plan, funding issues, cost risks] [Add financial information to the embedded chart—data included now is just to be used as an example] [Provide a short explanation of any significant deviation from the originally proposed spend plan]
Distribution Statement

12. Spend Plan Deviation Details/Mitigation plan
Distribution Statement